Trimethoprim/sulfamethoxazole, also known as co-trimoxazole and can beÂ abbreviated in the following ways: SXT, TMP-SMX, TMP-SMZ, or TMP-sulfa.

**The FDA-Approved Indications**

- Acute infective exacerbation of chronic bronchitis

- Otitis media in pediatrics only

- Travelers diarrhea for treatment and prophylaxis

- Urinary tract infections

- Shigellosis

- Pneumocystis jirovecii pneumonia/Pneumocystis carinii pneumonia (PJP/PCP) both prophylactic and treatment

- Toxoplasmosis both prophylactic and treatment

**The Non-FDA Approved Indications**

- Prophylaxis in HIV-infected individuals

- Acne vulgaris

- Listeria

- Melioidosis

- Pertussis (whooping cough)

- Staphylococcus aureus infections, including methicillin-resistant Staphylococcus aureus (MRSA)

- Tuberculosis

- Whipple disease

- Isosporiasis

- Malaria

- Community-acquired pneumonia